1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > MediPoint: Biopsy Devices - Current and Future Players

MediPoint: Biopsy Devices - Current and Future Players

  • February 2014
  • -
  • Global Data
  • -
  • 71 pages

MediPoint: Biopsy Devices - Current and Future Players

Summary

Cancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop biopsy devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient’s body. As seen with other medical device markets, less invasive biopsy techniques have entered the market and have established a new gold standard in many global regions.

The report identifies and analyzes the key companies shaping and driving the global Biopsy Devices market. The report provides insight into the competitive Biopsy Devices landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading cardiologists, with in-house analysis conducted by GlobalData’s team of industry experts.

Scope

- Investigation of current and future market competition for Biopsy Devices.
- Competitor assessment including device approval analysis.
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists using Biopsy Devices devices in clinical practice.

Reasons to buy

- Gain a high level view of the trends shaping and driving the Biopsy Devices market for coronary applications and peripheral applications in the lower extremity.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.

Table Of Contents

MediPoint: Biopsy Devices - Current and Future Players
1 Table of Contents

2 Introduction 7
2.1 Overview 7
2.2 Catalyst 8
2.3 Related Reports 8
3 Competitive Assessment 9
3.1 Overview 9
3.2 Company Market Share 9
3.2.1 Vacuum-Assisted Biopsy Market Share 10
3.2.2 Core Needle Biopsy/Fine Needle Aspiration Market Share 11
3.3 Classification Based on System 12
3.3.1 Vacuum-Assisted Biopsy Devices 12
3.3.2 Core Needle Biopsy Devices 14
3.3.3 Fine Needle Aspiration Devices 15
4 Pipeline Assessment 16
4.1 Overview 16
4.1.1 Optical Biopsy 17
4.1.2 Liquid Biopsy 18
5 Current and Future Players 19
5.1 Trends in Corporate Strategy 19
5.2 Company Profiles 19
5.2.1 Argon Medical Devices 19
5.2.2 Boston Scientific 22
5.2.3 Cardinal Health 25
5.2.4 CareFusion Corporation 26
5.2.5 Cook Medical 28
5.2.6 C. R. Bard 31
5.2.7 Devicor Medical Products 37
5.2.8 DTR Medical 41
5.2.9 Gallini Medical Devices 42
5.2.10 Hologic 45
5.2.11 INRAD 48
5.2.12 Intact Medical Corporation 50
5.2.13 TSK Laboratory 52
6 Appendix 54
6.1 Bibliography 54
6.2 Abbreviations 62
6.3 Report Methodology 65
6.3.1 Overview 65
6.3.2 Coverage 65
6.3.3 Primary Research 65
6.3.4 Secondary Research 66
6.3.5 Forecasting Methodology 67
6.4 Key Opinion Leaders Included in This Study 67
6.5 About the Authors 68
6.5.1 Joseph A. Gregory, Analyst, Surgical Devices 68
6.5.2 Derek Archila, MBA, Director of Research and Analysis, Medical Devices 68
6.6 Global Head of Healthcare 69
6.6.1 Bonnie Bain, Ph.D., Global Head of Healthcare 69
6.7 About MediPoint 70
6.8 About GlobalData 70
6.9 Disclaimer 70

1.1 List of Tables

Table 1: VAB, Global Market Share, 2013 10
Table 2: CNB/FNA, Global Market Share, 2013 11
Table 3: Company Profile - Argon Medical Devices 20
Table 4: Product Portfolio - Argon Medical Devices 21
Table 5: Argon Medical Devices, SWOT Analysis, 2013 21
Table 6: Company Profile - Boston Scientific 22
Table 7: Product Portfolio - Boston Scientific 24
Table 8: Boston Scientific SWOT Analysis, 2013 24
Table 9: Company Profile - Cardinal Health 25
Table 10: Product Portfolio - Cardinal Health 26
Table 11: Cardinal Health SWOT Analysis, 2013 26
Table 12: Company Profile - CareFusion Corporation 27
Table 13: Product Portfolio - CareFusion 28
Table 14: CareFusion, SWOT Analysis, 2013 28
Table 15: Company Profile - Cook Medical 29
Table 16: Product Portfolio - Cook Medical 30
Table 17: Cook Medical, SWOT Analysis, 2013 31
Table 18: Company Profile - C. R. Bard 32
Table 19: Product Portfolio - C. R. Bard 32
Table 20: C.R. Bard, SWOT Analysis, 2013 36
Table 21: Company Profile - Devicor Medical Products 37
Table 22: Product Portfolio - Devicor Medical Products 40
Table 23: Devicor Medical Products SWOT Analysis, 2013 40
Table 24: Company Profile - DTR Medical 41
Table 25: Product Portfolio - DTR Medical 41
Table 26: DTR Medical SWOT Analysis, 2013 42
Table 27: Company Profile - Gallini Medical Devices 43
Table 28: Product Portfolio - Gallini Medical Devices 44
Table 29: Gallini Medical Devices SWOT Analysis, 2013 44
Table 30: Company Profile - Hologic 45
Table 31: Product Portfolio - Hologic 47
Table 32: Hologic SWOT Analysis, 2013 47
Table 33: Company Profile - INRAD 48
Table 34: Product Portfolio - INRAD 49
Table 35: INRAD SWOT Analysis, 2013 49
Table 36: Company Profile - Intact Medical Corporation 50
Table 37: Product Portfolio - Intact Medical Corporation 51
Table 38: Intact Medical Corporation SWOT Analysis, 2013 51
Table 39: Company Profile - TSK Laboratory 52
Table 40: Product Portfolio - TSK Laboratory 53
Table 41: TSK Laboratory SWOT Analysis, 2013 53

1.2 List of Figures

Figure 1: VAB, Global Market Share, 2013 10
Figure 2: CNB/FNA, Global Market Share, 2013 11
Figure 3: EnCor Breast Biopsy System 33
Figure 4: EnCor Enspire Breast Biopsy System 34
Figure 5: EnCor Ultra Breast Biopsy System 34
Figure 6: Finesse Ultra Breast Biopsy System 35
Figure 7: Vacora Breast Biopsy System 36
Figure 8: Original Mammotome System 38
Figure 9: Mammotome Elite 39
Figure 10: Mammotome Revolve 40

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Liquid Biopsy Market: Global Industry Analysis and Opportunity Assessment 2016-2026

Liquid Biopsy Market: Global Industry Analysis and Opportunity Assessment 2016-2026

  • $ 5000
  • Industry report
  • August 2016
  • by Future Market Insight Global & Consulting Pvt Ltd

Report Synopsis This report by Future Market Insights (FMI) examines the ‘Liquid Biopsy Market’ for the period 2016–2026. The primary objective of the report is to offer updates and information ...

Breast Biopsy Device Market Analysis By Test Type, By Product, By Guidance Type, By Region And Segment Forecasts To 2024

Breast Biopsy Device Market Analysis By Test Type, By Product, By Guidance Type, By Region And Segment Forecasts To 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

The breast biopsy device market is expected to reach USD 911.2 million by 2024, according to a new report by Grand View Research, Inc. The Breast biopsy device market is projected to grow at a productive ...

Liquid Biopsy Market Size & Forecast By Application, By Sample Type, By Biomarker Type, By Technology and Trend Analysis from 2013 to 2030

Liquid Biopsy Market Size & Forecast By Application, By Sample Type, By Biomarker Type, By Technology and Trend Analysis from 2013 to 2030

  • $ 4950
  • Industry report
  • September 2016
  • by Grand View Research

Global liquid biopsies market is anticipated to reach 5,958.3 million by 2030, according to a new report by Grand View Research, Inc. As these less invasive biopsies are able to address a number of significant ...


Download Unlimited Documents from Trusted Public Sources

Biopsy Industry in the US

  • October 2016
    7 pages
  • Biopsy  

    Magnetic Resona...  

    Cancer  

  • United States  

View report >

Biopsy Industry in the US

  • August 2016
    2 pages
  • Biopsy  

  • United States  

    North America  

View report >

Biopsy Industry in the US

  • August 2016
    4 pages
  • Biopsy  

  • United States  

View report >

Related Market Segments :

Biopsy

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.